Leffel Discusses Third-Party Litigation Funding in Wisconsin Amid New Transparency Law
10 April 2018
Law.com
Partner Michael Leffel was quoted in a Law.com article, “What’s Next: A Groundbreaking Lit Funding Transparency Law, and More Pressure on Big Tech Over Privacy,” about the frequency of third-party litigation funding in Wisconsin amid the passing of Assembly Bill 773, which makes Wisconsin the first U.S. state to require the disclosure of third-party litigation funding in civil actions filed in state court.
“[Third-party litigation funding] is something that does not appear to be used that often in Wisconsin at this time,” said Leffel. Although there hasn’t been significant controversy over litigation funding in Wisconsin, Law.com reports the new law is the country’s first step toward uniform transparency rules on litigation funding contracts.
Subscription required.
“[Third-party litigation funding] is something that does not appear to be used that often in Wisconsin at this time,” said Leffel. Although there hasn’t been significant controversy over litigation funding in Wisconsin, Law.com reports the new law is the country’s first step toward uniform transparency rules on litigation funding contracts.
Subscription required.
People
Related News
27 November 2024
In the News
Lawrence Kraus Describes Loper Bright's Impact on False Claims Cases
Foley & Lardner LLP partner Lawrence Kraus is quoted in the Relias Media article, "Loper Bright Starting to Affect False Claims Cases."
26 November 2024
In the News
David Rosen on FDA GLP-1 Legal Battle – 'It's a precedent in this area'
Foley & Lardner LLP partner David Rosen described the legal battle between compounding pharmacies and the U.S. Food and Drug Administration over GLP-1 drugs in the BioSpace article, "Legal Challenge Over Lilly’s GLP-1 Shortages Highlights FDA’s Post-Chevron Vulnerability."
26 November 2024
In the News
Sara Abarbanel and Jacqueline Hayduk Assess Best Practices for Employee Assistance Programs
Employee assistance programs have become an extremely common benefit offered by U.S. employers.